Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Felley

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Inflammatory Bowel Diseases|April 22, 2011
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel diseaseStephan R Vavricka, Sabrina M Spigaglia, Gerhard Rogler, et al.
Inflammatory Bowel Diseases|June 16, 2011
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II surveyStephan R Vavricka, Alain M Schoepfer, Georg Bansky, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Inflammatory Bowel Diseases|April 22, 2011
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel diseaseStephan R Vavricka, Sabrina M Spigaglia, Gerhard Rogler, et al.
Inflammatory Bowel Diseases|June 16, 2011
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II surveyStephan R Vavricka, Alain M Schoepfer, Georg Bansky, et al.
Pageof 6